NASDAQ:CAPS Capstone Therapeutics Q2 2025 Earnings Report $0.37 -0.01 (-2.63%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$0.37 0.00 (-0.81%) As of 05/8/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Capstone Therapeutics EPS ResultsActual EPS-$0.13Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ACapstone Therapeutics Revenue ResultsActual Revenue$12.85 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACapstone Therapeutics Announcement DetailsQuarterQ2 2025Date8/15/2025TimeBefore Market OpensConference Call DateFriday, August 15, 2025Conference Call Time7:00AM ETUpcoming EarningsCapstone Therapeutics' Q1 2026 earnings is estimated for Thursday, May 28, 2026, based on past reporting schedulesConference Call ResourcesConference Call AudioConference Call TranscriptSlide DeckPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Capstone Therapeutics Q2 2025 Earnings Call TranscriptProvided by QuartrAugust 15, 2025 ShareLink copied to clipboard.Key Takeaways Positive Sentiment: Capstone reported material margin and profitability gains in Q2 — gross profit +13% and gross margin rose to 24.4% from 21.4%, EBITDA more than doubled to $839k and adjusted net income flipped to +$308k. Positive Sentiment: Capstone signed an accretive acquisition of Carolina Stone Products (purchase price $3.9M–$4.7M) adding ~$11M in revenue and ~$750k trailing EBITDA, with management expecting ~ $1M EBITDA in 2026 and immediate Southeast market entry. Positive Sentiment: Management emphasizes a disciplined M&A strategy with an active pipeline and target valuations of 4–6x EBITDA, aiming to reach a $100M revenue and $10M adjusted EBITDA run rate in 2026. Negative Sentiment: Revenue was essentially flat year‑over‑year and Capstone expects elevated first‑year corporate expenses (non‑recurring investor relations and other costs) that should normalize later in the year but could weigh on near‑term consolidated results. AI Generated. May Contain Errors.Conference Call Audio Live Call not available Earnings Conference CallCapstone Therapeutics Q2 202500:00 / 00:00Speed:1x1.25x1.5x2xThere are 1 speakers on the call. Operator00:00:00Welcome to Capstone Holding Corp's second quarter 2025 earnings presentation. Capstone is built to deliver, positioned to acquire, and ready to scale. This slide is our preamble and summary of our legal disclosure. The following content is fully qualified by the legal disclosures on the next two slides. Our goal is to share with you some of the strategic thinking and financial analysis we've been using to guide the growth of our business. This content aligns with our principles of being accountable and transparent with our shareholders. We operate in a hyper-dynamic environment. That's a fancy way of saying things change quickly. What we're telling you today is based on our best estimates and assumptions. We reserve the right to revise our views as new information becomes available. Despite uncertainty, we must plan. We must make operating and investment decisions. Operator00:00:58This presentation lays out some of that thinking for your review. In Q2, Instone delivered significant margin expansion and earnings growth. Revenue was essentially flat year-over-year, but gross profit increased 13%. Gross margin improved from 21.4% to 24.4%, driven by growth in our owned higher-margin brands. EBITDA more than doubled, up 120% from $374,000 in Q2 2024 to $839,000 in Q2 2025. Adjusted net income swung from a loss of $129,000 last year to a positive $308,000 this year. This quarter demonstrates the strength of our brand strategy and disciplined SG&A control. Today, we signed the agreement to acquire Carolina Stone Products, a leading stone veneer installer and distributor in North Carolina. The deal is expected to close within 10 days. Operator00:02:16Revenue is approximately $11 million, with trailing EBITDA of approximately $750,000. By 2026, we expect Carolina Stone to contribute $1 million in EBITDA. This is an immediately accretive acquisition. Carolina Stone provides immediate entry into the Southeast, one of the fastest-growing construction markets in the U.S. It establishes a platform for brand expansion and creates operating synergies across our business. This transaction is exactly what we outlined in our strategy. Disciplined acquisitions at attractive valuations that build scale and profitability. Our M&A pipeline remains active. We expect to close a second transaction within 60 days and are in discussions that could lead to a third by year-end. Favorable valuations, flexible deal structures, and disciplined execution keeps us on track to achieve $100 million in revenue and $10 million in EBITDA run rate for 2026. Operator00:03:21Earlier expectations of 100 basis points of rate cuts have shifted. Our current outlook calls for a 50 basis point cut later this year, which should support demand. In the meantime, we are delivering margin expansion and stronger profitability through cost discipline. With Carolina Stone and our growing product portfolio, Capstone is assembling the business needed to hit our 2026 targets. Capstone's target remains $100 million in run rate revenue and $10 million in run rate adjusted EBITDA for 2026. We are on track to close our first M&A transaction, Carolina Stone Products, within 10 days. Our acquisition funnel is active, and valuations remain attractive at 4-6x EBITDA. We are staying disciplined, focusing on tuck-ins that expand our platform and add earnings momentum. Rate cuts expected later in 2025 should improve demand and set up for a strong 2026. Operator00:04:26Carolina Stone is a premier installer and distributor of manufactured and natural stone veneer. It serves commercial, residential, and multifamily markets with premium brands, expert masonry installation, and strong project management. With warehouses and showrooms in North Carolina, it provides immediate coverage in the Triangle and Charlotte metros. This acquisition establishes Capstone's Southeast platform, expands distribution, and provides margin upside through higher-value products. The purchase price for Carolina Stone is $3.9 million with potential upside to $4.7 million. The multiple is 4.7x-5.2x EBITDA, in line with our disciplined acquisition criteria. Carolina Stone generates approximately $11 million in revenue and $750,000 in EBITDA. We expect this to grow to about $1 million of EBITDA in 2026. This transaction is a perfect fit with our strategy, disciplined, accretive, and growth-focused. Operator00:05:34Our M&A pipeline remains strong. Market conditions are producing realistic seller expectations and limited competition. Some of the best targets are waiting, and Capstone is nurturing those relationships. We expect an additional transaction from our active pipeline by year-end, with the potential to sign a third acquisition before 2025 closes. We are capitalizing on a favorable deal environment while staying disciplined. Our acquisition strategy remains unchanged, tuck-ins to expand our platform and add earnings momentum, sister companies with product and channel synergies to unlock cost savings and mutual growth, and new platforms longer term to drive their own tuck-ins. Valuations remain attractive at 4-6x EBITDA, typically with 20%-45% non-cash consideration. We remain disciplined on pricing, structure, and fit. Instone had a strong second quarter. Gross margins increased from 21.4%-24.4% year-over-year, reflecting the mix shift to owned higher-margin brands. Operator00:06:50SG&A stabilized towards an $8.5 million run rate. Toro and Pangaea are continuing to gain traction with dealers and expanded to new geographies. With rate cuts expected later in 2025, demand should improve. Combined with margin expansion and disciplined cost control, the groundwork is laid for a strong 2026. On this page and the next, you'll find a summary of Q2 results. Please refer to the 10-Q for more detail. As a public company, Capstone incurs corporate costs beyond those of its subsidiaries, currently Instone. Fixed costs include leadership, board, legal and compliance. Variable costs, like investor relations and marketing, can be scaled upwards or downwards as needed. When valuing our core business, we believe many corporate costs, including Capstone overhead, are non-essential to our subsidiaries' operations. Capstone corporate expenses are not expected to scale quickly as we grow, allowing Capstone to expand profitably as it executes its strategy. Operator00:08:30The first year includes a number of non-recurring expenses, such as higher investor relations spend. We expect Capstone expenses to normalize over the third and fourth quarter. These are our key principles, a promise to our investors. We will be transparent. We will always tell you how we are doing. We will be accountable. We will make commitments and share targets. Some may be stretch goals, but we will put our full effort behind them, and we will be adaptable. Markets change and conditions change. Capstone, ticker symbol CAPS, is executing with discipline, margin expansion, accretive M&A, and a clear path to the $100 million in revenue, $10 million EBITDA run rate goals.Read morePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Capstone Therapeutics Earnings HeadlinesCapstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 GuidanceMay 6 at 7:35 AM | businesswire.comCapstone Awarded Eldorado Stone Distribution, Targeting $5 Million in Organic Revenue GrowthApril 6, 2026 | businesswire.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. | InvestorPlace (Ad)Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue GrowthMarch 30, 2026 | businesswire.comCapstone unveils new firepit product as it aims for Q2 profitabilityMarch 10, 2026 | msn.comCapstone Expands Retail Portfolio as Order Volume Accelerates; Contractor Demand Drives Repeat Revenue and EBITDA GrowthMarch 10, 2026 | businesswire.comSee More Capstone Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Capstone Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Capstone Therapeutics and other key companies, straight to your email. Email Address About Capstone TherapeuticsCapstone Therapeutics (NASDAQ:CAPS), a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.View Capstone Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Rocket Lab Posts Record Q1 Revenue, Raises Q2 GuidanceHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusAppLovin Pops After Earnings With Growth Catalysts in SightDutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality CheckThe AI Fear Around Datadog Stock May Have Been Completely WrongAmprius Technologies Ups the Voltage on Forward OutlookWhy Lam Research Still Looks Like a Buy After a 300% Rally Upcoming Earnings Constellation Energy (5/11/2026)Barrick Mining (5/11/2026)Petroleo Brasileiro S.A.- Petrobras (5/11/2026)Simon Property Group (5/11/2026)SEA (5/12/2026)Cisco Systems (5/13/2026)Alibaba Group (5/13/2026)Manulife Financial (5/13/2026)Sumitomo Mitsui Financial Group (5/13/2026)Takeda Pharmaceutical (5/13/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 1 speakers on the call. Operator00:00:00Welcome to Capstone Holding Corp's second quarter 2025 earnings presentation. Capstone is built to deliver, positioned to acquire, and ready to scale. This slide is our preamble and summary of our legal disclosure. The following content is fully qualified by the legal disclosures on the next two slides. Our goal is to share with you some of the strategic thinking and financial analysis we've been using to guide the growth of our business. This content aligns with our principles of being accountable and transparent with our shareholders. We operate in a hyper-dynamic environment. That's a fancy way of saying things change quickly. What we're telling you today is based on our best estimates and assumptions. We reserve the right to revise our views as new information becomes available. Despite uncertainty, we must plan. We must make operating and investment decisions. Operator00:00:58This presentation lays out some of that thinking for your review. In Q2, Instone delivered significant margin expansion and earnings growth. Revenue was essentially flat year-over-year, but gross profit increased 13%. Gross margin improved from 21.4% to 24.4%, driven by growth in our owned higher-margin brands. EBITDA more than doubled, up 120% from $374,000 in Q2 2024 to $839,000 in Q2 2025. Adjusted net income swung from a loss of $129,000 last year to a positive $308,000 this year. This quarter demonstrates the strength of our brand strategy and disciplined SG&A control. Today, we signed the agreement to acquire Carolina Stone Products, a leading stone veneer installer and distributor in North Carolina. The deal is expected to close within 10 days. Operator00:02:16Revenue is approximately $11 million, with trailing EBITDA of approximately $750,000. By 2026, we expect Carolina Stone to contribute $1 million in EBITDA. This is an immediately accretive acquisition. Carolina Stone provides immediate entry into the Southeast, one of the fastest-growing construction markets in the U.S. It establishes a platform for brand expansion and creates operating synergies across our business. This transaction is exactly what we outlined in our strategy. Disciplined acquisitions at attractive valuations that build scale and profitability. Our M&A pipeline remains active. We expect to close a second transaction within 60 days and are in discussions that could lead to a third by year-end. Favorable valuations, flexible deal structures, and disciplined execution keeps us on track to achieve $100 million in revenue and $10 million in EBITDA run rate for 2026. Operator00:03:21Earlier expectations of 100 basis points of rate cuts have shifted. Our current outlook calls for a 50 basis point cut later this year, which should support demand. In the meantime, we are delivering margin expansion and stronger profitability through cost discipline. With Carolina Stone and our growing product portfolio, Capstone is assembling the business needed to hit our 2026 targets. Capstone's target remains $100 million in run rate revenue and $10 million in run rate adjusted EBITDA for 2026. We are on track to close our first M&A transaction, Carolina Stone Products, within 10 days. Our acquisition funnel is active, and valuations remain attractive at 4-6x EBITDA. We are staying disciplined, focusing on tuck-ins that expand our platform and add earnings momentum. Rate cuts expected later in 2025 should improve demand and set up for a strong 2026. Operator00:04:26Carolina Stone is a premier installer and distributor of manufactured and natural stone veneer. It serves commercial, residential, and multifamily markets with premium brands, expert masonry installation, and strong project management. With warehouses and showrooms in North Carolina, it provides immediate coverage in the Triangle and Charlotte metros. This acquisition establishes Capstone's Southeast platform, expands distribution, and provides margin upside through higher-value products. The purchase price for Carolina Stone is $3.9 million with potential upside to $4.7 million. The multiple is 4.7x-5.2x EBITDA, in line with our disciplined acquisition criteria. Carolina Stone generates approximately $11 million in revenue and $750,000 in EBITDA. We expect this to grow to about $1 million of EBITDA in 2026. This transaction is a perfect fit with our strategy, disciplined, accretive, and growth-focused. Operator00:05:34Our M&A pipeline remains strong. Market conditions are producing realistic seller expectations and limited competition. Some of the best targets are waiting, and Capstone is nurturing those relationships. We expect an additional transaction from our active pipeline by year-end, with the potential to sign a third acquisition before 2025 closes. We are capitalizing on a favorable deal environment while staying disciplined. Our acquisition strategy remains unchanged, tuck-ins to expand our platform and add earnings momentum, sister companies with product and channel synergies to unlock cost savings and mutual growth, and new platforms longer term to drive their own tuck-ins. Valuations remain attractive at 4-6x EBITDA, typically with 20%-45% non-cash consideration. We remain disciplined on pricing, structure, and fit. Instone had a strong second quarter. Gross margins increased from 21.4%-24.4% year-over-year, reflecting the mix shift to owned higher-margin brands. Operator00:06:50SG&A stabilized towards an $8.5 million run rate. Toro and Pangaea are continuing to gain traction with dealers and expanded to new geographies. With rate cuts expected later in 2025, demand should improve. Combined with margin expansion and disciplined cost control, the groundwork is laid for a strong 2026. On this page and the next, you'll find a summary of Q2 results. Please refer to the 10-Q for more detail. As a public company, Capstone incurs corporate costs beyond those of its subsidiaries, currently Instone. Fixed costs include leadership, board, legal and compliance. Variable costs, like investor relations and marketing, can be scaled upwards or downwards as needed. When valuing our core business, we believe many corporate costs, including Capstone overhead, are non-essential to our subsidiaries' operations. Capstone corporate expenses are not expected to scale quickly as we grow, allowing Capstone to expand profitably as it executes its strategy. Operator00:08:30The first year includes a number of non-recurring expenses, such as higher investor relations spend. We expect Capstone expenses to normalize over the third and fourth quarter. These are our key principles, a promise to our investors. We will be transparent. We will always tell you how we are doing. We will be accountable. We will make commitments and share targets. Some may be stretch goals, but we will put our full effort behind them, and we will be adaptable. Markets change and conditions change. Capstone, ticker symbol CAPS, is executing with discipline, margin expansion, accretive M&A, and a clear path to the $100 million in revenue, $10 million EBITDA run rate goals.Read morePowered by